Topic: Excessive pricing

The Dutch competition authority has launched a preliminary investigation to determine if three pharmaceutical companies are tying their services and charging excessive prices to both healthcare and insurance providers.

25 January 2023

Three former Southern California Edison employees failed to allege that their former employer illegally prevented them from doing electrical work in the state, a federal court has ruled.

13 January 2023

China’s antitrust watchdog has fined an online academic literature database €12.1 million for abusing its dominance by imposing excessively high subscription fees and forcing users into exclusivity arrangements.

09 January 2023

Israel’s Competition Authority has fined drug distributor MBI Pharma €2.2 million for abusing its dominance by charging unfairly high prices for a life-saving genetic disorder treatment drug, marking the enforcer’s first-ever excessive pricing infringement decision.

14 December 2022

The market definition used by the UK’s Competition and Markets Authority when fining Auden McKenzie for excessive pricing wrongly excluded a competitor’s more expensive substitute product, counsel to the sanctioned drugmaker has claimed.

14 December 2022

Lithuania’s Competition Council has levied a record €72 million cartel fine on eight pharmaceutical companies and an industry association that conspired to influence the government when it set new maximum prices for certain drugs.

13 December 2022

India’s specialist antitrust tribunal has ordered the country's competition watchdog to reduce the €208 million price-fixing fines it levied against five tyre companies, due to “inadvertent and arithmetical” calculation errors and to save the wider market.

06 December 2022

A group of Taylor Swift fans is suing Ticketmaster for allegedly harming competition in the online ticketing sector and violating the consent order behind its merger with Live Nation.

06 December 2022

Law firm Leigh Day plans to file the UK’s first-ever "environmental" collective action against several wastewater companies accused of breaching the country's antitrust rules, a week after an economic consultancy urged the country’s competition authority to open a probe based on the same allegations.

24 November 2022

An in-house lawyer at a drugmaker since bought out by Advanz Pharma allowed the company’s most senior staff to hold meetings without strictly abiding by certain compliance rules, counsel to the UK's Competition and Markets Authority has claimed.

23 November 2022